LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES
The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridi...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Müller, Simone Gröttrup-Wolfers, Esther Ingwersen, Jan-Peter Hilpert, Jan |
| description | The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridin-3-yl)estra-1,3,5(10),16-tetraen-3-yl]carbonyl}-N-methyl-²-alanine per day.. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3269373A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3269373A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3269373A13</originalsourceid><addsrcrecordid>eNrjZPD28Q_XdfEPdnVR8A9y9FEAMh3dXRXc_IN8FfzdFBz9FBy9gwydjRU8_Tw8nTxD_INAcgohQa6OIb6ufiEgRS6ewa6Owa7BPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2MjM0tjc2NHQmAglAOKDLLE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES</title><source>esp@cenet</source><creator>Müller, Simone ; Gröttrup-Wolfers, Esther ; Ingwersen, Jan-Peter ; Hilpert, Jan</creator><creatorcontrib>Müller, Simone ; Gröttrup-Wolfers, Esther ; Ingwersen, Jan-Peter ; Hilpert, Jan</creatorcontrib><description>The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridin-3-yl)estra-1,3,5(10),16-tetraen-3-yl]carbonyl}-N-methyl-²-alanine per day..</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180117&DB=EPODOC&CC=EP&NR=3269373A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180117&DB=EPODOC&CC=EP&NR=3269373A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Müller, Simone</creatorcontrib><creatorcontrib>Gröttrup-Wolfers, Esther</creatorcontrib><creatorcontrib>Ingwersen, Jan-Peter</creatorcontrib><creatorcontrib>Hilpert, Jan</creatorcontrib><title>LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES</title><description>The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridin-3-yl)estra-1,3,5(10),16-tetraen-3-yl]carbonyl}-N-methyl-²-alanine per day..</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPD28Q_XdfEPdnVR8A9y9FEAMh3dXRXc_IN8FfzdFBz9FBy9gwydjRU8_Tw8nTxD_INAcgohQa6OIb6ufiEgRS6ewa6Owa7BPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2MjM0tjc2NHQmAglAOKDLLE</recordid><startdate>20180117</startdate><enddate>20180117</enddate><creator>Müller, Simone</creator><creator>Gröttrup-Wolfers, Esther</creator><creator>Ingwersen, Jan-Peter</creator><creator>Hilpert, Jan</creator><scope>EVB</scope></search><sort><creationdate>20180117</creationdate><title>LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES</title><author>Müller, Simone ; Gröttrup-Wolfers, Esther ; Ingwersen, Jan-Peter ; Hilpert, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3269373A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Müller, Simone</creatorcontrib><creatorcontrib>Gröttrup-Wolfers, Esther</creatorcontrib><creatorcontrib>Ingwersen, Jan-Peter</creatorcontrib><creatorcontrib>Hilpert, Jan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Müller, Simone</au><au>Gröttrup-Wolfers, Esther</au><au>Ingwersen, Jan-Peter</au><au>Hilpert, Jan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES</title><date>2018-01-17</date><risdate>2018</risdate><abstract>The present invention relates to a low-dosed oral dosage form for treatment and/or prophylaxis of diseases, especially of endometriosis, polycystic ovary syndrome and atopic dermatitis. More particularly, the present invention concerns oral dosage forms comprising up to 120 mg N-{[17-(5-Fluoropyridin-3-yl)estra-1,3,5(10),16-tetraen-3-yl]carbonyl}-N-methyl-²-alanine per day..</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3269373A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | LOW-DOSED ORAL DOSAGE FORM OF AN AKR1C3 INHIBITOR FOR TREATMENT OF DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A30%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=M%C3%BCller,%20Simone&rft.date=2018-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3269373A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |